Development and Evaluation of a Web-based Diet Quality Screener for Vegans - BELGIUM
- Conditions
- Healthy
- Registration Number
- NCT06861205
- Lead Sponsor
- University Ghent
- Brief Summary
The primary objective of this study is to assess the construct validity and criterion validity for associations of the VEGANScreener with nutrient intakes from reference methods and associations with biomarkers of dietary intake. The investigators hypothesize that the screener is a valid tool to assess diet quality in the vegan population. The study will assess construct validity by testing whether the measure relates as it should to other measures (e.g., age, gender, education, socioeconomic status differences).
The investigators will assess concurrent and predictive validity (types of criterion validity) by evaluating associations and agreement between 'gold standards', such as diet records, biomarkers, and multi-metabolite signatures of intake. The investigators will examine associations of vegan diet quality with biomarkers of nutritional status, biomarkers of disease, and anthropometric measures and hypothesize that a higher diet quality in vegans is associated with a more favourable profile among vegans, for example, a lower blood pressure. This study is part of the European VEGANScreener Consortium.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 200
- Self-reported vegans (≥2 years on a vegan diet; vegan diet defined as not consuming any dietary animal products more often than once/month, honey excluded)
- Self-reported omnivores. Consuming on average daily (at least 5 times/week) meat/meat products.
- Age 18 to 65 years (1:1 ratio 18-35,99 and 36-65)
- Males and females (1:1 ratio)
- Self-identified pescatarians (excluding all meat, except for fish/seafood) and reductarians/flexitarians (intentionally reducing intake of animal-based products)
- History of a disease known to affect intermediary metabolism (e.g., any diabetes on treatment, i.e. medication or lifestyle recommendations, thyreopathies, cancer etc.)
- BMI>30 kg/m2
- History of disease of intestinal integrity (i.e., inflammatory bowel disease, chronic pancreatitis, other malabsorption, etc.).
- Pregnant or breastfeeding females.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validity of the vegan screener Baseline The validity will be assessed by calculating associations between the screener and reference method.
- Secondary Outcome Measures
Name Time Method Dietary intake Baseline Dietary intake will be assessed using a weighed food record
Food habits Baseline Food habits will be assessed using a food frequency questionnaire
Vitamin D status Baseline Vitamin D status will be measured from venous blood samples
Homocysteine status Baseline Homocysteine will be measured from venous blood samples
Ferritin concentration Baseline Ferritin concentration will be determined from venous blood samples
Soluble transferrin receptor concentration Baseline Soluble transferrin receptor will be determined from venous blood samples
holo-transcobalamin Baseline holo-transcobalamin will be measured from venous blood samples
Methylmalonic acid Baseline Methylmalonic acid will be measured from venous blood samples
Folic acid status Baseline Folic acid will be measured from venous blood samples
Vitamin B2 status Baseline Vitamin B2 will be measured from venous blood samples
Zinc status Baseline Zinc status will be determined from venous blood samples
Selenoprotein-P status Baseline Selenoprotein-P status will be determined from venous blood samples
Creatinine concentration Baseline Creatinine will be determined from venous blood samples
Uric acid concentration Baseline Uric acid will be determined from venous blood samples
Urea concentration Baseline Urea will be determined from urine samples samples
Iodine concentration Baseline Iodine status will be determined from urine samples
Potassium concentration Baseline Potassium status will be determined from urine samples
Sodium concentration Baseline Sodium status will be determined from urine samples
Vitamin C status Baseline Vitamin C will be measured from venous blood samples
Magnesium status Baseline Magnesium status will be determined from venous blood samples
Hemoglobin concentration Baseline Hemoglobin will be determined from venous blood samples
Calcium concentration Baseline Calcium status will be determined from urine samples
Creatinine concentration (urine) Baseline Creatinine will be determined from urine samples
C-reactive protein concentration Baseline The inflammatory marker hsCRP will be determined from serum
Triglyceride concentration Baseline Triglyceride concentration will be determine from venous blood samples
Free fatty acid concentration Baseline Free fatty acid concentration will be determine from venous blood samples
Eicosapentanoic acid Baseline Eicosapentanoic acid (in % of total FA) will be determine from venous blood samples
Docosahexanoic acid Baseline Docosahexanoic acid (in % of total FA) will be determine from venous blood samples
LDL-cholesterol concentration Baseline LDL-cholesterol concentration will be determine from venous blood samples
HDL-Cholesterol concentration Baseline HDL-Cholesterol concentration will be determine from venous blood samples
Cholesterol concentration Baseline Cholesterol concentration will be determine from venous blood samples
Glucose concentration Baseline Glucose will be measured from venous blood samples
Well being Baseline Participants well being will be assessed using a questionnaire. The scale of each question ranges from 0 to 10, 10 representing the highest well being
VEGANScreener Baseline and day 2 The VEGANScreener assesses diet quality using 29 questions of frequency of consumption of different foods and food groups.
Weight Baseline Weight will be measured in kg
Height Baseline Height will be measured in m
Waist circumference Baseline Waist circumference will be measured in cm
Hip circumference Baseline Hip circumference will be measured in cm
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
UZ Gent
🇧🇪Ghent, Belgium